Stefana Morgan1, Bruce Cooper2, Steven Paul2, Marilyn J Hammer3, Yvette P Conley4, Jon D Levine5, Christine Miaskowski2, Laura B Dunn6. 1. Department of Psychiatry, University of California, San Francisco. 2. School of Nursing, University of California, San Francisco. 3. Mount Sinai Medical Center. 4. School of Nursing, University of Pittsburgh. 5. School of Dentistry, University of California, San Francisco. 6. Department of Psychiatry and Behavioral Sciences, Stanford University.
Abstract
Background: This study identified latent classes of cancer patients based on Big Five personality dimensions and evaluated for differences in demographic and clinical characteristics, depression, anxiety, and cancer-related symptoms. Methods: Patients (n=1248) with breast, gastrointestinal, gynecological, or lung cancer completed the Center for Epidemiological Studies-Depression scale, Spielberger State-Trait Anxiety Inventories, NEO-Five Factor Inventory (NEO-FFI), and Memorial Symptom Assessment Scale (MSAS). Latent class profile analysis of NEO-FFI scores was used to identify patient subgroups. Results: Three latent classes were identified. The "Distressed" class (14.3%) scored highest on neuroticism and lowest on extraversion, agreeableness, and conscientiousness. The "Resilient" class (31.9%) scored lowest on neuroticism and highest on extraversion, agreeableness, and conscientiousness. The "Normative" class (53.8%) was intermediate on all dimensions except openness. Compared to the Resilient class, patients in the Distressed class were younger, less educated, more likely to care for another adult, had more comorbidities, and exercised less. The three classes differed by performance status, marital and employment status, and income, but not by gender, time since diagnosis, or type of prior cancer treatment. The classes differed (Distressed > Normative > Resilient) in depression, anxiety, and cancer symptoms. Conclusions: Personality is associated with psychological and physical symptoms in cancer patients.
Background: This study identified latent classes of cancerpatients based on Big Five personality dimensions and evaluated for differences in demographic and clinical characteristics, depression, anxiety, and cancer-related symptoms. Methods:Patients (n=1248) with breast, gastrointestinal, gynecological, or lung cancer completed the Center for Epidemiological Studies-Depression scale, Spielberger State-Trait Anxiety Inventories, NEO-Five Factor Inventory (NEO-FFI), and Memorial Symptom Assessment Scale (MSAS). Latent class profile analysis of NEO-FFI scores was used to identify patient subgroups. Results: Three latent classes were identified. The "Distressed" class (14.3%) scored highest on neuroticism and lowest on extraversion, agreeableness, and conscientiousness. The "Resilient" class (31.9%) scored lowest on neuroticism and highest on extraversion, agreeableness, and conscientiousness. The "Normative" class (53.8%) was intermediate on all dimensions except openness. Compared to the Resilient class, patients in the Distressed class were younger, less educated, more likely to care for another adult, had more comorbidities, and exercised less. The three classes differed by performance status, marital and employment status, and income, but not by gender, time since diagnosis, or type of prior cancer treatment. The classes differed (Distressed > Normative > Resilient) in depression, anxiety, and cancer symptoms. Conclusions: Personality is associated with psychological and physical symptoms in cancerpatients.
Authors: B E Compas; M F Stoll; A H Thomsen; G Oppedisano; J E Epping-Jordan; D N Krag Journal: Breast Cancer Res Treat Date: 1999-04 Impact factor: 4.872
Authors: Helen J Michielsen; Alida F W Van der Steeg; Jan A Roukema; Jolanda De Vries Journal: Support Care Cancer Date: 2007-02-07 Impact factor: 3.603
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Mark de Mol; Sabine Visser; Joachim Aerts; Paul Lodder; Nico van Walree; Huub Belderbos; Brenda den Oudsten Journal: BMC Cancer Date: 2020-05-18 Impact factor: 4.430
Authors: Maria Velia Giulietti; Anna Vespa; Marica Ottaviani; Rossana Berardi; Giancarlo Balercia; Giorgio Arnaldi; Pisana Gattafoni; Paolo Fabbietti; Mirko Di Rosa; Roberta Spatuzzi Journal: Cancer Control Date: 2019 Jan-Dec Impact factor: 3.302
Authors: Danielle B Tometich; Kelly A Hyland; Hatem Soliman; Heather S L Jim; Laura Oswald Journal: Cancers (Basel) Date: 2020-12-08 Impact factor: 6.639